Additionally, P4HA2 is correlated with eight immune checkpoint molecules in colorectal adenocarcinoma, including PD-L1 (47), and all the above studies suggest that the regulation of PD-L1 expression by P4HA2 is related to immunotherapy. The gene discussed is P4HA2; the disease is colorectal adenocarcinoma.